The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients. 

Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?

The new-look adjustable stents, not yet fully approved by the FDA, can be expanded as a child ages. The hope is that these stents will never need to be replaced.

The group will examine data from approximately 1,600 patients, focusing on the relationship between the heart and the aorta. 

The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a joint statement aimed at updating the rules and regulations associated with randomized clinical trials

Oversized devices are becoming more common as time goes on, which suggests operators are growing increasingly comfortable with this treatment choice.

Researchers have completed a new analysis of the Evolut Pro and Pro+ devices from Medtronic and the Sapien 3 Ultra devices from Edwards Lifesciences, sharing the results in JACC: Cardiovascular Interventions.

Prior to the Dec. 15 announcement, CMS had released a different statement in June informing the public that they were reconsidering the amount of PET scans that Alzheimer’s patients undergoing monoclonal antibody treatment can receive.

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.